Showing papers for search query "FDA+Requirement"+"Regulated+Environment"+"Testing"

     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future
     Author ['AC Segreti', 'HM Leung', 'GG Koch', 'RL Davis']
     Venue Journal of …
     Year 2001
     Abstract BIOPHARMACEUTICAL STATISTICS IN A PHARMACEUTICAL REGULATED ENVIRONMENT: PAST, PRESENT, AND FUTURE  Gradually, an FDA requirement appeared for at least two independent positive  Problems arose when the statistical testing was significant in a one
     Url https://www.tandfonline.com/doi/abs/10.1081/BIP-120008853


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Model‐Based Systems Engineering as an Enabler for Regulatory Design Compliance
     Author ['J Dean', 'C Henderson', 'J Gardner']
     Venue INCOSE International …
     Year 2012
     Abstract These prototypes are planned as part of the risk mitigation activity and their testing is tied to  systems engineering is being used on this project due to the FDA regulated environment, although the  Table 1: FDA Process Records FDA$Requirement$ Process$Record/Deliverable
     Url https://onlinelibrary.wiley.com/doi/abs/10.1002/j.2334-5837.2012.tb01473.x


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title REGULATORY ASPECT OF PHARMACEUTICAL CHANGE CONTROL SYSTEM
     Author ['D Sharma', 'V Sharma']
     Venue Journal of Drug Delivery and Therapeutics
     Year 2011
     Abstract Scientific judgment should determine what additional testing & validation studies are needed to  training and procedures is a major industry problem, especially in a regulated environment  Reinforcement training, an FDA requirement, is targeted for performers to maintain their
     Url http://www.jddtonline.info/index.php/jddt/article/view/6


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Equipment qualification for demonstrating the fitness for purpose of analytical instrumentation
     Author ['DG Jones']
     Venue Analyst
     Year 1998
     Abstract Some industries, which operate in a highly regulated environment, such as the pharmaceutical industry  of this investigation it emerged that effectively the company was 'testing into compliance'  It is now an FDA requirement to investigate formally all out-of- specification results
     Url https://pubs.rsc.org/en/content/articlehtml/1998/an/a804670k


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title 21 CFR part 11: Complete guide to international computer validation compliance for the pharmaceutical industry
     Author ['O López']
     Venue NA
     Year 2004
     Abstract computer systems validation, and gives my readers a clear picture on how they must work effectively in a quality role in today's high-pressure, regulated environment  More verification and testing are always required, and there are serious risks associated with skipping them
     Url https://books.google.com/books?hl=en&lr=&id=X3qmDwAAQBAJ&oi=fnd&pg=PP1&dq=%22FDA+Requirement%22+%22Regulated+Environment%22+%22Testing%22&ots=DZ3-4h3aIE&sig=BWzZvemw4GWTpKpbrxHZgQysNcs


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Cost-contained regulatory compliance: for the pharmaceutical, biologics, and medical device industries
     Author ['S Weinberg']
     Venue NA
     Year 2011
     Abstract Partially as a result of paranoia, partially because of FDA lack of clarity, and partially a result of evolutionary force (“most companies are testing 20 samples; let's test 25 just to be safe”; “they tested 25 at my old company; let's use 30 as a standard to avoid problems
     Url https://books.google.com/books?hl=en&lr=&id=qAZri2M0yTEC&oi=fnd&pg=PR1&dq=%22FDA+Requirement%22+%22Regulated+Environment%22+%22Testing%22&ots=Eccixqdq4r&sig=3z2QEcxijlYwlz0QDuGuMr3CSpY


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Evaluating Twitter as a complementary data source for pharmacovigilance
     Author ['J Lardon', 'F Bellet', 'R Aboukhamis', 'H Asfari']
     Venue Expert opinion on …
     Year 2018
     Abstract Challenge–dechallenge–rechallenge is 'a medical testing protocol in which a medicine or drug is administered, withdrawn, then re-administered, while being monitored for ADRs at each stage.' 2 Indeed, positive dechallenge (disappearance of the ADR when the drug is
     Url https://www.tandfonline.com/doi/abs/10.1080/14740338.2018.1499724


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Dynamic Incentives: Improving the Safety, Effectively, and Availability of Medical Products through Progressively Increasing Damage Caps for Manufacturers
     Author ['SS Evans']
     Venue U. Ill. L. Rev.
     Year 2007
     Abstract However, the author also acknowledges a criti- cal shortcoming associated with the implementation of these tort li- ability protections — reduced manufacturer incentive to perform ade- quate post-approval surveillance and testing
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/unilllr2007&section=38


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Pharmaceutical efficacy: the illusory legal standard
     Author ['JJ Darrow']
     Venue Wash. & Lee L. Rev.
     Year 2013
     Abstract Food, Drug, and Cosmetic Act5 requires only that there be "substantial evidence that the drug will have the effect it purports or is represented to have."6 It is the thesis of this Article that this standard, along with the related concepts of gold standard testing, statistical significance
     Url https://heinonline.org/hol-cgi-bin/get_pdf.cgi?handle=hein.journals/waslee70&section=51


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Developing a measurement system for the pharmaceutical compliance process using the Balanced Scorecard
     Author ['G Bader']
     Venue NA
     Year 2007
     Abstract FDA found that Puritan-Bennett's Boulder and Carlsbad plants violated federal safeguards, such as inadequate equipment testing, failure to  Another paper that ponders the issue of a Balanced Scorecard in a regulated environment is Balancing the Scorecard: Key Performance
     Url http://search.proquest.com/openview/5c32007f93951f8b9bf00e33810c1968/1?pq-origsite=gscholar&cbl=18750&diss=y


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title The Impact of Total Quality Performance on Compliance
     Author ['C Medina']
     Venue DRUGS AND THE PHARMACEUTICAL SCIENCES
     Year 2004
     Abstract of nonreportable events can prove to be very valuable during phase IV postmarketing studies, although this is not an FDA requirement  Research is de¢ ned as a systematic investigation, including research development testing and evaluation designed to develop or contri- bute
     Url http://ndl.ethernet.edu.et/bitstream/123456789/502/1/34.pdf#page=510


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title The application of dried blood spots in toxicokinetic and pharmacokinetic studies
     Author ['M Barfield']
     Venue NA
     Year 2017
     Abstract and utilized filter papers. Other early adopters (1925-1950) reported interesting benefits when using DBS for syphilis testing. Notable advantages included reduced sample volumes, inexpensive as using filter papers, enhanced stability and reduced
     Url http://eprints.lincoln.ac.uk/30876/1/30876%20Barfield%20Matt%20Chemistry%20Septemer%202017.pdf


     Search term "FDA+Requirement"+"Regulated+Environment"+"Testing"
     Title Analytical tools for suspension characterization
     Author ['AF Rawle']
     Venue Pharmaceutical suspensions
     Year 2010
     Abstract 6.3.1 Particle Size and Dissolution. There is a basic (FDA) requirement to study the dissolution enshrined in USP XXIII <711>  Apparatus for testing the dissolution of a solid material is commonly seen in pharmaceutical analytical laboratories in the form of paddle testers
     Url https://link.springer.com/chapter/10.1007/978-1-4419-1087-5_6

